Actemra actpen 162 MG/0.9 ML 0.9ML
Ended Awarded Last action
- Contract number
- SPE2DR26F18QN
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $92,518
Award facts
- Contract value 100% obligated
- $92,517.65 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $92,517.65 to AmerisourceBergen Drug Corp for the supply of Actemra ActPen 162 mg/0.9 mL auto-injector pens. The contract, executed on November 25, 2025, with an ultimate completion date of November 26, 2025, utilizes firm fixed pricing with no set-aside designation, indicating competitive award. Performance will be executed from the vendor's location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen Drug Corp's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, a $999.999 billion prime vendor agreement designated as SPE2DX and extending through December 2026.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, serves as a critical federal medical procurement vendor specializing in pharmaceutical products and medical supplies for military and veteran healthcare systems. The company's substantial IDC with DLA enables it to supply a comprehensive range of medications across multiple therapeutic domains to support Defense Health Agency, U.S. Coast Guard, and other government healthcare customers globally. Actemra (tocilizumab) is a biologic immunosuppressant medication used in treating rheumatoid arthritis and other inflammatory conditions, representing the type of specialty pharmaceutical products the vendor routinely delivers through its federal medical supply contracts.
Quick answers
Who was awarded contract SPE2DR26F18QN?
SPE2DR26F18QN was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on November 25, 2025.
How much is contract SPE2DR26F18QN worth?
The government has obligated $92,518 on SPE2DR26F18QN.
Is contract SPE2DR26F18QN an order under another contract?
Yes. SPE2DR26F18QN is a delivery order under SPE2DR25D3301, an indefinite delivery contract.
Was contract SPE2DR26F18QN competed?
The extent of competition for SPE2DR26F18QN was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award